Postoperative biochemical recurrence occurs in up to 40% of prostate carcinoma patients treated with radical prostatectomy. Primary tumor grade and cribriform architecture are important parameters for clinical outcome; however, their relevance at positive surgical margins has not been completely elucidated yet. We reviewed 835 radical prostatectomy specimens and recorded pT-stage, surgical margin status, Grade Group, and cribriform architecture of the primary tumor and at positive surgical margins. Clinicopathologic parameters and biochemical recurrence-free survival (BCRFS) were used as endpoints. Positive surgical margins were present in 284 (34%) patients, with a median cumulative length of 5.0 mm. In 46%, the Grade Group at the margin was equal to the primary tumor grade, while being lower in 42% and higher in 12%. In multivariable analysis, Grade Group at the margin outperformed the Grade Group of the primary tumor in predicting BCRFS. Among primary Grade Group 2 patients, 56% had Grade Group 1 disease at the margin. Multivariable analysis identified cumulative length, Grade Group at the margin, and lymph node metastasis as independent predictors for BCRFS, while percentage Gleason pattern 4, tertiary Gleason pattern 5 of the primary tumor, and cribriform architecture at the margin were not. In conclusion, the Grade Group at the positive surgical margin was dissimilar to the primary tumor grade in 54% and better predicted BCRFS than the primary tumor grade. Cumulative length and tumor grade at the margin were independent predictors for BCRFS, whereas cribriform architecture at the margin was not.
R adical prostatectomy is one of the first-line treatment options in men with intermediate-risk to high-risk prostatic carcinoma. Even in technically well-executed surgical procedures, pathologic evaluation of radical prostatectomy specimens reveals positive surgical margins in 8% to 34% of patients. [1] [2] [3] [4] [5] [6] [7] [8] Therewith, prostatic carcinoma has the highest incidence of positive surgical margins among male malignancies. 9 After surgical treatment, biochemical recurrence occurs in up to 40% of patients. [10] [11] [12] The Gleason Score/Grade Group, tumor stage, and surgical margin status are the most important histopathologic predictors of clinical outcome. [13] [14] [15] [16] [17] [18] [19] Overall, 30% of patients with positive surgical margins develop biochemical recurrence, as opposed to 10% with negative surgical margins. 20 Brimo et al 21 were the first to describe the prognostic significance of the tumor grade at the surgical margin. Together with the cumulative length of the positive surgical margin, they are independent predictors for biochemical recurrence. 5, [21] [22] [23] [24] [25] Detailed microscopic analysis of surgical margins might reveal additional parameters associated with clinical outcome.
In the last decade, invasive cribriform Gleason pattern 4 has been recognized as a reproducible and independent predictive parameter for biochemical recurrence, metastasis, and disease-specific death. [26] [27] [28] [29] [30] The relation of cribriform architecture with surgical margin status and clinical outcome has, however, not been elucidated yet. The aim of this study was to determine the predictive value of the Grade Group and cribriform architecture at the surgical margin in relation to clinical outcome after radical prostatectomy.
MATERIALS AND METHODS

Patient Selection
We included 854 patients who had undergone radical prostatectomy for prostatic carcinoma at the Erasmus MC University Medical Center, Rotterdam, The Netherlands, between 2000 and 2017. Men who had undergone neoadjuvant hormonal, radiation, or gene therapy (n = 19) were excluded from this study, leaving 835 patients for analysis. 31 After formalin fixation, radical prostatectomy specimens were cut transversally into 4 mm sections. The apical and basal slides were further sectioned perpendicular to the surgical margin, after which the entire specimen was submitted for histologic analysis. All slides were available for pathologic review. The analysis of tissue samples for scientific purposes was approved by the institutional Medical Research Ethics Committee (MEC-2018-1614). Samples were processed in accordance with the "Code for Proper Secondary Use of Human Tissue in The Netherlands", as established by the Dutch Federation of Medical Scientific Societies (FMWV, version 2002, update 2011).
Histopathologic Evaluation
A detailed review of each radical prostatectomy specimen was performed by 2 investigators (E.H., G.J.L. H.v.L.), blinded for initial diagnosis and clinical outcome. The following features were monitored: Gleason Score and Grade Group according to the International Society of Urological Pathology (ISUP) 2014 guidelines, pT-stage according to the American Joint Committee on Cancer (AJCC) TNM 8th edition, and surgical margin status. 32, 33 The percentages of Gleason pattern 3, 4, and 5 were estimated, including presence of tertiary Gleason patterns. The presence of cribriform architecture was recorded, in which no distinction was made between invasive cribriform and intraductal carcinoma. Large expansive cribriform pattern was defined as having a diameter of at least twice the size of adjacent preexistent normal glands.
A positive surgical margin was defined as tumor glands and/or fields extending into the ink at the specimen's surface. Length of the positive surgical margin was measured using a microruler and annotated in millimeters. Cumulative length was used for analysis. In addition, the Grade Group score and presence of cribriform architecture at the positive surgical margin were recorded. When the surgical margin was not optimally assessable because of surgical thermal artifacts, directly adjacent tumor fields were evaluated. To differentiate between tumor grade present at the positive surgical margin and the Grade Group of the entire tumor mass, we refer to the latter as "primary tumor."
Clinical Follow-Up
Management of patients with prostatic carcinoma after radical prostatectomy consisted of 6-monthly and later annual monitoring of serum prostate-specific antigen (PSA) levels. Biochemical recurrence was defined as an increased PSA ≥ 0.2 ng/ml, measured at 2 consecutive points in time, after being undetectable after radical prostatectomy or, if serum PSA level did not decline to 0 ng/ml after the operation, as an increase of > 2.0 ng/ml. Postoperative lymph node and distant metastases were confirmed by pathologic tissue evaluation or by multidisciplinary consensus.
Statistical Analysis
The independent samples t test and analysis of variance were used for normally distributed, continuous variables, whereas the Mann-Whitney U test was used for variables without normal distribution. Categorical values were analyzed using Pearson χ 2 test. Median PSA values were imputed when PSA levels were missing (n = 45), using the median PSA level for each specific Grade Group. Cox proportional hazards regression was used for biochemical recurrence-free survival. Survival curves were created using the Kaplan-Meier method. Statistics were performed using IBM SPSS 24 (IBM Corp., Chicago, IL). Results were considered significant when the 2-sided P-value <0.05.
RESULTS
Patient Characteristics
The cohort consisted of 835 patients with a median age of 64.6 years (interquartile range [IQR] = 60.2 to 68.1) and median PSA level of 8.2 ng/ml (IQR = 5.7 to 13.0). The cohort included 207 (25%) men with Grade Group 1, 420 (50%) with Grade Group 2, 101 (12%) with Grade Group 3, 50 (6%) with Grade Group 4, and 57 (7%) with Grade Group 5 prostatic carcinoma. Cribriform architecture was observed in 417 (50%) men and large cribriform pattern in 65 (23%) men. Distribution of pathologic stage was as follows: 476 (57%) pT2, 263 (32%) pT3a, 93 (11%) pT3b, and 3 (0.4%) pT4. In total, 284 (34%) patients had positive surgical margins at radical prostatectomy. Positive surgical margins were present in 35 (17%) Grade Group 1, 142 (34%) Grade Group 2, 47 (47%) Grade Group 3, 23 (46%) Grade Group 4, and 37 (65%) Grade Group 5 tumors. Pelvic lymph node dissection was performed in 190 (67%) men and was positive in 33 (17%) cases.
The median length of the positive surgical margin was 5.0 mm (IQR = 2.2 to 9.5). Patients with positive surgical margins presented with higher PSA levels (P < 0.001), and showed more advanced pT-stage (P < 0.001) and higher Grade Group (P < 0.001) than patients with negative surgical margins. Among 249 men with Grade Group 2 to 5 prostatic carcinoma with positive surgical margins, 184 (74%) had cribriform architecture within the primary tumor, compared with 224/379 (59%, P < 0.001) surgical marginnegative patients. Clinicopathologic characteristics of surgical margin-positive patients are summarized in Table 1 .
Distribution of Grade Groups at the Positive Surgical Margin
In 130 (46%) cases with positive surgical margins, the Grade Group of the primary tumor was similar to the Grade Group at the margin. In 120 (42%) cases, the Grade Group at the margin was lower than that of the primary tumor and, in 34 (12%) cases, it was higher. The distribution of Grade Groups at the positive surgical margins is shown in Table 2 .
As the Grade Groups of the primary tumor increased, the positive surgical margin was more often bilateral (P < 0.001) and the cumulative length increased (P < 0.001). In total, 27 men had cribriform architecture at the surgical margin, representing 11% of all Grade Group 2 to 5 tumors with positive margins. Twenty patients (74%) with cribriform architecture at the surgical margin had large cribriform growth pattern in the primary tumor, compared with 45/220 (20%) of men without cribriform growth at the margin (P < 0.001).
Surgical Margin Grade Group is Associated With Biochemical Recurrence-free Survival
The median follow-up of the entire cohort was 53.8 months (IQR = 15.6 to 104.8). In total, 126 of 284 (44%) men with positive surgical margins developed biochemical recurrence, as compared with 94/551 (17%) men with negative surgical margin status (P < 0.001). Median time to biochemical recurrence was significantly shorter (P < 0.001) in surgical margin-positive patients (17.1 mo, IQR = 7.4 to 39.0) than in negative patients (27.1 mo, IQR = 11.2 to 58.0).
Univariate analysis in patients with positive surgical margins showed that PSA level (P < 0.001), pT-stage (P < 0.001), positive lymph nodes (P < 0.001), length of positive surgical margin (P < 0.001), Grade Group of both primary tumor (P = 0.008) and at the surgical margin (P < 0.001), and presence of cribriform architecture in both primary tumor (P < 0.001) and at the surgical margin (P < 0.001) were all significant predictors for biochemical recurrence-free survival ( Table 3 ). In multivariable analysis, PSA level (P = 0.002), positive lymph nodes (P = 0.02), surgical margin length (P = 0.02), and Grade Group at the site of the positive surgical margin (P = 0.001) were independent predictors for biochemical recurrence-free survival, whereas the Grade Group of the primary tumor, pT-stage, and cribriform architecture in both the primary tumor (P = 0.06) and at the margin (P = 0.16) were not.
Length of the positive surgical margin was also analyzed as a dichotomous parameter using cutoff values of ≤ 1 and ≤ 3 mm. For patients with ≤ 1 mm positive surgical margin, the biochemical recurrence rate was 7/40 (18%), and, for those with ≤ 3 mm, the rate was 40/111 (36%). Biochemical recurrence-free survival of patients with a positive surgical margin of ≤ 1 mm did not significantly differ from that of patients with negative surgical margins (log-rank P = 0.85), but did from that of patients with > 1 mm margin (log-rank P < 0.001). Patients with ≤ 3 mm margin had worse biochemical recurrence-free survival compared with those with negative surgical margins (log-rank P < 0.001), but had better outcome than patients with > 3 mm margin (log-rank P < 0.001).
Detailed Pathologic Characterization of Grade Group 2 Patients With Positive Surgical Margins
The effects of Gleason pattern 4, cribriform architecture, and tertiary pattern 5 were further analyzed in Grade Group 2 prostatic carcinoma patients, of whom 142/420 (34%) had positive surgical margins. The median GG SM  GG1  GG2  GG3  GG4  GG5  Total   GG1  34  80  6  6  0  126  GG2  1  52  11  4  2  70  GG3  0  9  12  0  2  23  GG4  0  1  14  8  9  32  GG5  0  0  4  5  24  33  Total  35 percentage Gleason pattern 4 was 20% (IQR = 10% to 30%), and 17 (12%) men had presence of tertiary Gleason pattern 5. Cribriform growth was seen in 90 (63%) men. The Grade Group at the surgical margin matched the Grade Group of the primary tumor in 52 (37%) cases, while 80 (56%) men had Grade Group 1 at the margin. Ten (7%) men had a higher tumor grade at the margin. Biochemical recurrence occurred significantly less in patients with Grade Group 1 at the positive surgical margin (20/80, 25%) than in those with Grade Group 2 at the surgical margin (25/52, 48%, P = 0.002). Although patients with Grade Group 1 at the margin had higher rates of biochemical recurrence than men with negative surgical margins (44/278, 16%), this did not meet conventional measures of statistical significance in this cohort (P = 0.06). The median time to biochemical recurrence was significantly longer in patients with Grade Group 1 compared with that in patients with Grade Group 2 at the surgical margin (log-rank P < 0.001, Fig. 1 ), but was not significantly different from men with negative surgical margins (log-rank P = 0.08). Univariate analysis showed that PSA (P = 0.05), pT-stage, positive lymph nodes (P = 0.001), length of the positive surgical margin (P < 0.001), Grade Group at the margin (P < 0.001), and presence of cribriform growth (P = 0.001) at the margin were associated with biochemical recurrence-free survival, whereas percentage Gleason pattern 4 (P = 0.77) in the primary tumor, presence of tertiary pattern 5 (P = 0.99), and cribriform architecture in the primary tumor (P = 0.20) were not (Table 4 ). Multivariable analysis revealed that positive lymph nodes (P = 0.003), length of the positive surgical margin (P < 0.001), and Grade Group at the margin were independent predictors for biochemical recurrence-free survival in Grade Group 2 patients with positive surgical margins, but cribriform architecture at the margin (P = 0.40) was not.
Distant Metastasis
Patients with Grade Group 1 of the primary tumor did not develop metastases, however, 2/126 (2%) men with Grade Group 1 at the positive surgical margin did. Among Grade Group 2 to 5 patients, 60 (10%) distant metastases were reported. Distant metastases were significantly more often seen in positive surgical margin patients (33/284, 12%) than in negative surgical margin patients (27/551, 5%, P < 0.001). Among 184 men with cribriform architecture in the primary tumor, no significant difference was observed in the development of metastases in patients with (7/27, 26%) and without (20/157, 13%, P = 0.20) cribriform growth at the surgical margin.
DISCUSSION
To identify patients with low risk for biochemical recurrence and to aid patient selection for postoperative radiotherapy, we studied the effect of the Grade Group at the positive surgical margin on biochemical recurrence-free survival. In our cohort, 34% of patients had a positive surgical margin with a median length of 5.0 mm. In 46% of cases, the Grade Group of the positive surgical margin matched the Grade Group of the primary tumor, while 42% had a lower and 12% a higher Grade Group at the margin. Patients with positive surgical margins developed biochemical recurrence significantly more often than those with negative surgical margins. In multivariable analysis, the Grade Group at the surgical margin outperformed the Grade Group of the primary tumor in predicting biochemical recurrence-free survival. Among Grade Group 2 prostatic carcinoma patients, 37% had the same Grade Group at the surgical margin, while 56% had lower and 10% higher Grade Group. Multivariable analysis identified the cumulative length of the positive margin, Grade Group at the margin, and lymph node metastasis as independent predictors for biochemical recurrence-free survival, while cribriform architecture at the margin, and percentage Gleason pattern 4 and tertiary Gleason pattern 5 in the primary tumor were not.
Considering its adverse effect on biochemical recurrence-free survival, surgical margin status is an important parameter for adjuvant treatment decision-making. 34 The European Association of Urology (EAU) recommends postoperative radiotherapy when there is a high risk of local failure with extraprostatic extension or positive margins. 34 The National Comprehensive Cancer Network (NCCN) advises adjuvant radiotherapy in case of adverse features such as positive surgical margins. 35 The Grade Group at the positive surgical margin is currently not considered in these guidelines. As there is growing consensus that grade of the tumor at the positive surgical margin is an independent prognostic factor, it should be included in pathology guidelines in addition to length of the positive surgical margin. Furthermore, consensus should be reached as to how to report tumor grade at the surgical margin, being either Grade Group or presence of Gleason pattern 3, 4, or 5.
Despite the positive surgical margin rates, use of adjuvant radiotherapy after a positive surgical margin is decreasing, even in patients with adverse features. [36] [37] [38] Bhindi et al 39 showed that adjuvant radiotherapy was associated with reduced risk of biochemical recurrence, in a cohort with 20 years of follow-up, including 152 patients with pT2N0 tumors and positive surgical margins. However, metastasis-free or overall survival benefits were not seen, stressing the complex relation between biochemical recurrence and metastatic disease progression.
Although the relationship between positive surgical margins and biochemical recurrence has been well established, the effect of positive surgical margins on long-term survival has not yet been elucidated. 2, 6, 7, [16] [17] [18] In their re- 40 showed no significant impact of positive surgical margins on long-term survival in multivariable analysis, as they did not find an increase in mortality when adjusting for variables related to the aggressiveness of disease. Stephenson et al 41 concluded that positive surgical margins alone were not associated with an increased risk of disease-specific mortality. In contrast, Chalfin et al 42 found that positive surgical margins were significant predictors for cancer-specific mortality, even after adjusting for Gleason Score and pathologic stage. Wright et al 43 concluded in a large cohort study that positive margin status is an independent predictor for cancer-specific mortality, also in multivariable analysis. Radical prostatectomy is frequently complicated by erectile dysfunction and incontinence. Nerve-sparing surgery, in which the neurovascular bundles are left intact unilaterally or bilaterally, can reduce these adverse effects, but might result in slightly higher positive surgical margin rates and biochemical recurrence. [44] [45] [46] [47] However, patients with limited positive surgical margins might have similar outcomes as patients with negative surgical margins. 1, 5, 22, [48] [49] [50] [51] To find an optimal balance between maximum nerve-sparing surgery without negatively affecting oncologic outcome, intraoperative frozen sections of prostate surgical margins are being performed in some centers. 52, 53 Detailed histopathologic assessment of tumor length and grade at the surgical margin might, therefore, be relevant in clinical decision-making during surgery. As patients with limited cumulative length and Grade Group 1 at the positive surgical margin have low risk of biochemical recurrence, urologists might intraoperatively decide not to remove the entire neurovascular bundle in these cases.
The strengths of our study are the detailed histologic review of the primary tumor and surgical margin status including cribriform architecture. The main limitation of this study was the relatively short follow-up of 54 months. Unfortunately, no information was available on nervesparing surgery and adjuvant therapy.
In conclusion, we found that tumor grade at the positive surgical margin was dissimilar to the Grade Group of the primary tumor in 54% and better predicted biochemical recurrence-free survival than the primary tumor grade. Tumor length and grade at the surgical margin were both independent predictors for biochemical recurrence, while cribriform architecture at the surgical margin was not. Detailed histopathologic evaluation of surgical margins might support clinical decision-making with regard to postoperative radiotherapy or nervesparing surgery.
